KaloCyte, Inc.
PrivateLast Round
Grant
Apr 15, 2024
Total Funding Raised
$11.84M
Momentum Score
25 /100
Company Overview
KaloCyte, Inc. is a biotechnology company developing ErythroMer™, a dried, bio-inspired artificial red blood cell substitute for use when stored red blood cells are unavailable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Defense Tech, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KaloCyte, Inc. Comps
Public and private peers based on sector, stage, and business model.
KaloCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2024 | ||||
| Debt | Jul 17, 2023 | ||||
| Grant | Feb 3, 2023 | ||||
| Convertible Debt | Jul 20, 2022 | ||||
| Convertible Debt | Jul 20, 2020 | ||||
Seed | Jun 8, 2020 |
Key People
Founding team and executive leadership
KaloCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Debt |
| Old Line Capital Partners | Convertible Debt |
| University System of Maryland Momentum Fund | Seed, Convertible Debt |
| National Institutes of Health (NIH) | Grant |
| NYBC Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2025
Selected to join collaboration with Johnson & Johnson and BARDA.
KaloCyte, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KaloCyte, Inc.'s valuation, stock price, and market status.
